Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of tumor suppressor genes
Luc G.T. Morris, Timothy A. Chan
Cancer (2014) Vol. 121, Iss. 9, pp. 1357-1368
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 422
New insights into M1/M2 macrophages: key modulators in cancer progression
Jiuyang Liu, Xia-Fei Geng, Jinxuan Hou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 338
Regulating tumor suppressor genes: post-translational modifications
Ling Chen, Shuang Liu, Yongguang Tao
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 324
Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives
Sweta Nidhi, Uttpal Anand, Patrik Olekšák, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3327-3327
Open Access | Times Cited: 184
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 167
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Muhammad Javed Iqbal, Ayesha Kabeer, Zaighum Abbas, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 119
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
Oleg Timofeev, Philippe Giron, Steffen Lawo, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 20
Analysis of cancer-related lncRNAs using gene ontology and KEGG pathways
Lei Chen, Yuhang Zhang, Guohui Lu, et al.
Artificial Intelligence in Medicine (2017) Vol. 76, pp. 27-36
Closed Access | Times Cited: 155
Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities
Roodolph St. Pierre, Cigall Kadoch
Current Opinion in Genetics & Development (2017) Vol. 42, pp. 56-67
Open Access | Times Cited: 154
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
Mrinal M. Gounder, Alona Zer, William D. Tap, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 26, pp. 3166-3174
Open Access | Times Cited: 151
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
Rohith Srivas, John Paul Shen, Chih Cheng Yang, et al.
Molecular Cell (2016) Vol. 63, Iss. 3, pp. 514-525
Open Access | Times Cited: 150
Oncogenic regulation of tumor metabolic reprogramming
Míriam Tarrado‐Castellarnau, Pedro de Atauri, Marta Cascante
Oncotarget (2016) Vol. 7, Iss. 38, pp. 62726-62753
Open Access | Times Cited: 140
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 96
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma
Ludwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Cancer Research (2020) Vol. 80, Iss. 20, pp. 4335-4345
Open Access | Times Cited: 81
Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
Lee Jy, Richie R. Bhandare, Sai H. S. Boddu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116275-116275
Open Access | Times Cited: 9
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis
Manuela Lanzafame, Gaia Bianco, Luigi Terracciano, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 682-682
Open Access | Times Cited: 81
Opportunities and challenges in combination gene cancer therapy
Kent L. Nastiuk, John J. Krolewski
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 35-40
Open Access | Times Cited: 73
ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1
Jun Yin, Wenfan Fu, Lu Dai, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 65
Combinatorial drug therapy in cancer - New insights
Karanpreet Singh Bhatia, Bhumika, Asmita Das
Life Sciences (2020) Vol. 258, pp. 118134-118134
Closed Access | Times Cited: 56
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
Man Wu, Xueqing Xia, Jiemiao Hu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Exploring liver cancer biology through functional genetic screens
Cun Wang, Ying Cao, Chen Yang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 690-704
Closed Access | Times Cited: 44
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 1, pp. 3-18
Closed Access | Times Cited: 31
Evolving strategies and application of proteins and peptide therapeutics in cancer treatment
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114832-114832
Open Access | Times Cited: 20
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Drug repurposing and prediction of multiple interaction types via graph embedding
E. Amiri Souri, Alicia M. Chenoweth, Sophia N. Karagiannis, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top